UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000001449
Receipt number R000001752
Scientific Title Clinical study of Sublingal immunotherapy with Lactobacillus strain for patients with Japanese cedar pollinosis : A Randomized Placebo-Controlled Trial
Date of disclosure of the study information 2008/10/21
Last modified on 2009/12/06 16:42:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical study of Sublingal immunotherapy with Lactobacillus strain for patients with Japanese cedar pollinosis : A Randomized Placebo-Controlled Trial

Acronym

Lactobacillus strain Th1 adjuvant for sublingal allergy vaccine

Scientific Title

Clinical study of Sublingal immunotherapy with Lactobacillus strain for patients with Japanese cedar pollinosis : A Randomized Placebo-Controlled Trial

Scientific Title:Acronym

Lactobacillus strain Th1 adjuvant for sublingal allergy vaccine

Region

Japan


Condition

Condition

Japanese cedar pollen allergy

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To Study the efficacy and safety of Lactobacillus strain(LAB) Th1 adjuvant for the sublingal immunotherapy(SLIT) of patients with Japanese cedar pollinosis.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase III


Assessment

Primary outcomes

ISymptom-medication score

Key secondary outcomes

Local findings in rhinoscope
Serum anti-Japanese cedar pollen specific IgE antibody
Serum ECP level
Lymphocyte Subsets of Peripheral Blood Mononuclear Cell (Immunophenotyping)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine Food

Interventions/Control_1

From December 2008 to May 2009, patients of control 1 receive active treatment and 1 LAB tablet at 5 times per week. The induction/build-up phase is 3 weeks, with an increasing daliy number of the extract drops at three consentrations.

Interventions/Control_2

From December 2008 to May 2009, patients of control 1 receive active treatment and 1 placebo tablet at 5 times per week. The induction/build-up phase is 3 weeks, with an increasing daliy number of the extract drops at three consentrations.

Interventions/Control_3

From December 2008 to May 2009, patients of control 2 receive and 1 LAB tablet at 5 times per week.The induction/build-up phase is 3 weeks,with an increasing daliy number of the placebo drops as control 1.

Interventions/Control_4

From December 2008 to May 2009, patients of control 2 receive and 1 placebo tablet at 5 times per week.The induction/build-up phase is 3 weeks,with an increasing daliy number of the placebo drops as control 1.

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1)Clinical history of cedar pollen-induced allergic rhinoconjunctivitis for at least 2 years
2)Positive specific IgE to cry j1/2 antigen(CAP-RAST>=class2)

Key exclusion criteria

1)The history of severe asthma
2)The history of anti-allergic drugs within 4 weeks
3)Perior history of immunotherapy with cedar pollen
4)Pregnant women and those at risk of pregnancy
5)Complication of the other nasal-paranasal disease

Target sample size

100


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yoshitaka Okamoto

Organization

Chiba University Graduate School

Division name

Department of Otorhinolaryngology

Zip code


Address

1-8-1 Inohana,Chuo-ku Chiba 260-8677

TEL

043-226-2137

Email



Public contact

Name of contact person

1st name
Middle name
Last name Shigetoshi Horiguchi

Organization

Chiba University Graduate School

Division name

Department of Otorhinolaryngology

Zip code


Address

1-8-1 Inohana,Chuo-ku, Chiba, 260-8677

TEL

043-226-2137

Homepage URL


Email

jibika@office.chiba-u.jp


Sponsor or person

Institute

Department of Otorhinolaryngology in Ciba University Graduate School

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labour and Welfare

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2008 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2008 Year 10 Month 21 Day

Date of IRB


Anticipated trial start date

2008 Year 11 Month 01 Day

Last follow-up date

2009 Year 07 Month 01 Day

Date of closure to data entry

2010 Year 07 Month 01 Day

Date trial data considered complete

2010 Year 07 Month 01 Day

Date analysis concluded

2010 Year 07 Month 01 Day


Other

Other related information



Management information

Registered date

2008 Year 10 Month 21 Day

Last modified on

2009 Year 12 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000001752


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name